PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1145254
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1145254
Europe ultrasound gels market is projected to register a substantial CAGR of 6.1% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
Europe Ultrasound Gels Market, By Type (Sterile Ultrasound Gels, Non-Sterile Ultrasound Gels), Application (Hysterosonography, Obstetric Ultrasound, Abdominal Ultrasound, Breast Ultrasound, Carotid Ultrasound, Musculoskeletal Ultrasound, Pelvic Ultrasound, Prostate Ultrasound, Scrotal Ultrasound, Thyroid Ultrasound, Venous Ultrasound, Others), End User (Hospitals, Clinics, Diagnostic Center, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales,), Country (Europe,). This region is further segmented into major countries such as Germany, France, Italy, U.K., Spain, Netherlands, Switzerland, Belgium, Turkey, and Rest of Europe. Industry Trends and Forecast to 2029.
Medline Industries LP
Deas s.r.l
HR Pharmaceuticals Inc
FIAB SpA,
Gima S.p.A
Parker Laboratories Inc
Primax Berlin GmbH
Optimum Medical Limited
Safersonic
Braun and Co. Limited
ProSys International Ltd
Turquoise Health
DJO LLC, Fannin
Lessa (Subsidiary of AB Medica Group)
Rays S.P.A
Resonance health